July 12, 2023
The Cancer Research & Treatment Fund (CR&T) is proud to host the 12th International Patient Symposium for individuals with myeloproliferative neoplasms (MPNs), their family, and friends. Patients and guests attending this day-long symposium will learn about the latest research developments and treatment practices from distinguished MPN researchers and physicians. This is a unique opportunity to engage with guest speakers from the most prestigious cancer centers in the world.
Speakers/Topics include:
- Drivers of Progression of MPNs: Ronald Hoffman, M.D.
- Managing Essential Thrombocythemia in 2023: Ellen K. Ritchie, M.D.
- The Microbiomes in the MPNs: Hans Hasselbalch, M.D., Ph.D.
- Managing Polycythemia Vera in 2023: Richard T. Silver, M.D.
- Inflammation in MPNs: Angela Fleischman, M.D., Ph.D.
- Managing Myelofibrosis in 2023: Jerry L. Spivak, M.D.
- Promising new drugs for MPN therapy: Naveen Pemmaraju, M.D.
- Demystifying bone marrow transplant for MPNs: Roni Tamari, M.D.
- Moderated Q&A: Ghaith Abu-Zeinah, M.D. - Moderator, and Entire Panel
- Disease-Specific Q&A Groups (moderated by Symposium presenters):
-Polycythemia Vera - Drs. Abu-Zeinah, Hasselbach, Hoffman, and Silver
-Essential Thrombocythemia - Drs. Fleischman, Ritchie, and Schafer
-Myelofibrosis - Drs. Pemmaraju, Spivak, and Tamari
Registration Includes:
- Continental Breakfast
- Conference program and materials
- Access to all sessions
- Morning and afternoon coffee/snack breaks
- Access to sponsor tables
- Box Lunch
- Admission to the evening wine/cheese reception
- Discount code to MPN Congress
Scholarships available. Please contact Chad Feay at cfeay@crt.org for assistance.